Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023

BUY
$1.79 - $2.85 $19,417 - $30,916
10,848 New
10,848 $25,000
Q4 2022

Feb 15, 2023

BUY
$1.14 - $2.11 $19,899 - $36,832
17,456 New
17,456 $29,000
Q2 2022

Aug 09, 2022

BUY
$2.15 - $6.01 $25,241 - $70,557
11,740 New
11,740 $25,000

Others Institutions Holding LIAN

About LianBio


  • Ticker LIAN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 108,354,000
  • Market Cap $31.4M
  • Description
  • LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...
More about LIAN
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.